Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Somantin |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyrotropin releasing factor |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxytocin |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamic releasing factor |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prolactin releasing factor (substance) |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Short-acting thyroid stimulator |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Corticotropin binding globulin (substance) |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lipotropin |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Melanocyte stimulating hormone releasing factor |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamic inhibiting factor |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Melanocyte stimulating hormone |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cataglykin (substance) |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neurophysin |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Melanocyte hormone inhibiting factor |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary luteinizing hormone |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prolactin inhibiting factor |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bovine growth hormone |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatotropin binding globulin |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Long-acting thyroid stimulator |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary hormone |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Exophthalmos producing substance |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Posterior pituitary hormone |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyrotropin binding globulin |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Combined pituitary function test (procedure) |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin/thyrotrophin releasing hormone/gonadotrophin releasing hormone test |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Augmented insulin stress test |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Propranolol/thyrotrophin releasing hormone/gonadotrophin releasing hormone test |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadotrophin releasing hormone test |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamus hormone radioassay |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum gonadotrophin studies |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary hormone - serum measurement |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Laboratory test of hypothalamic and pituitary hormones (procedure) |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin analogue |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gonadotropin releasing hormone receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 1500iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 2000iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
choriogonadotropine alfa 5000 UI, ampoule de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 10,000iu injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urofollitrophin 75iu injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Luteinizing hormone releasing hormone antagonist product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cetrorelix (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetrorelix 0.25mg injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acétate de cétrorélix 3 mg, fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ganirelix (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ganirelix 0.25mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 75units(FSH) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamic/pituitary hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gonad regulating hormone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadotrophic hormone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urofollitrophin 150units injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing urofollitropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotropin preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypophysiostatic factor preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamic+anterior pituitary hormones |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 75iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 150iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antidiuretic hormone antagon. [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonadotrophin release hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ganirelix acetate 250mcg/0.5ml injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary follicle stimulating hormone 150 unit and pituitary luteinising hormone 150 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urofollitropin 75iu powder for injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin alfa 250micrograms injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing recombinant human chorionic gonadotrophin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing choriogonadotropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Follitropin recombinant 75iu/luteinizing hormone 75iu/sodium chloride 9% wv powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Abarelix-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plenaxis |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Abarelix 100mg powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plenaxis 100mg powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 150units(FSH) injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin alfa 250micrograms injection powder for reconstitution+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 75iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotrophins 150iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing human chorionic gonadotropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ganirelix 0.25mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin alfa 250micrograms injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anterior pituitary hormone |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gonad regulating hormone agent (substance) |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by posterior pituitary hormone |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamic/pituitary hormone poisoning |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental vasopressin poisoning |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional vasopressin poisoning |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vasopressin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamic/pituitary hormone allergy |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adverse reaction caused by hypothalamic/pituitary hormone |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by pituitary hormone |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by vasopressin |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Posterior pituitary hormone poisoning NOS |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenocorticotropin challenge tests |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Corticotropin, big fragment measurement |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenocorticotropic hormone measurement (procedure) |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Measurement of serum adrenocorticotropic hormone (procedure) |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plasma adrenocorticotropic hormone level (procedure) |
Component |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamic/pituitary hormone overdose |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tesamorelin (substance) |
Is a |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypothalamic/pituitary hormone allergy |
Causative agent (attribute) |
False |
Hypothalamic and pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |